What we know about coronavirus vaccines for children under 12

1 152
Published on 24 Sep 2021, 15:12
Pfizer-BioNTech announced that a lower dose of its vaccine triggered a robust immune response in younger children. The company still has to submit a formal application to the FDA so the vaccine can be reviewed for emergency use authorization. Read more: wapo.st/3AEqqO5. Subscribe to The Washington Post on YouTube: wapo.st/2QOdcqK

Follow us:
Twitter: twitter.com/washingtonpost
Instagram: instagram.com/washingtonpost
Facebook: facebook.com/washingtonpost